The Spanish National Assembly has annulled a fine of €20 million weighing over major energy company Repsol imposed in 2015 by the market regulator, the National Commission of Markets and Competition (CNMC). The company had appealed the procedure on grounds that the CNMC imposed the sanction on the parent company and not on the relevant subsidiary that should have been targeted instead.
_
The case stands out for being the second time that Repsol has dodged sanctions for this reason in a short time: on July 28, the Court annulled another fine of €22.6 million that the CNMC had imposed on Repsol because the regulator assigned that sanction to the parent of the group, Repsol SA.
_
In February 2015, following a series of raids and investigations, the CNMC determined that a price coordination agreement had been reached between gas stations that were chartered between Repsol and Cepsa over various periods between 2011 and 2013.
_
Repsol, in its appeal, recalled that Repsol SA does not carry out any marketing activity at service stations, and that this is a function of its subsidiary, Repsol Comercial de Productos Petrolíferos SA, owned by Repsol at 99.78%, and the rightful target for sanctions.
Full Content: El País
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump’s Executive Actions Signal a New Era for Cryptocurrency Regulation
Jan 21, 2025 by
CPI
Norton Rose Adds Antitrust Partners in Italy
Jan 20, 2025 by
CPI
Antitrust Lawsuit Over Google’s Search Monopoly Proceeds in CA Court
Jan 20, 2025 by
CPI
Digital Markets Act at Two Years: Enforcement in a Shifting Political Climate
Jan 20, 2025 by
CPI
EU Expands Tech Oversight with Updated Anti-Hate Speech Code
Jan 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan